Optoacoustic imaging of naphthalocyanine: Potential for contrast enhancement and therapy monitoring

Journal of Nuclear Medicine

Volumn 56, Issue 2, 2015, Pages 323-328

  Bézière, Nicolas ^a   Ntziachristos, Vasilis ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Imaging; Naphthalocyanine; Optoacoustic; Photoacoustic; Photodynamic therapy

Indexed keywords

CREMOPHOR; INDOCYANINE GREEN; OXYGEN; RADIOPHARMACEUTICAL AGENT; REACTIVE OXYGEN METABOLITE; SILICON 2, 3 NAPHTHALOCYANINE BI(TRIHEXYLSILYLOXIDE); UNCLASSIFIED DRUG; WATER; 2,3-NAPHTHALOCYANINE; BIS(TRI-N-HEXYLSILOXY)(2,3-NAPHTHALOCYANINATO)SILICON; CONTRAST MEDIUM; PORPHYRIN; SILANE DERIVATIVE;

ACOUSTICS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL REACTION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LASER; LIGHT ABSORPTION; LIGHT RELATED PHENOMENA; MOUSE; NONHUMAN; PATIENT MONITORING; PHANTOM; PHOTOACOUSTIC TOMOGRAPHY; PHOTOACOUSTICS; PHOTOSTABILITY; PHOTOTHERAPY; THERAPY MONITORING; TUMOR VOLUME; VOLUME OF DISTRIBUTION; ANIMAL; CHEMISTRY; IMAGE QUALITY; LIGHT; NUDE MOUSE; OPTICS; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CONTRAST MEDIA; FEMALE; LIGHT; MICE; MICE, NUDE; OPTICS AND PHOTONICS; OXYGEN; PHANTOMS, IMAGING; PHOTOACOUSTIC TECHNIQUES; PORPHYRINS; REACTIVE OXYGEN SPECIES; SILANES;

EID: 84922042318     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.114.147157     Document Type: Article

References (25)

1. Roeder B, Naether D, Lewald T, Braune M, Nowak C, Freyer W. Photophysical properties and photodynamic activity in vivo of some tetrapyrroles. Biophys Chem. 1990;35:303-312.
2. Dougherty TJ, Gomer CJ, Jori G, et al. Photodynamic therapy. J Natl Cancer Inst. 1998;90:889-905.
3. Brown SB, Brown EA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 2004;5:497-508.
4. Davids LM, Kleemann B. Combating melanoma: the use of photodynamic therapy as a novel, adjuvant therapeutic tool. Cancer Treat Rev. 2011;37:465-475.
5. Tandon YK, Yang MF, Baron ED. Role of photodynamic therapy in psoriasis: a brief review. Photodermatol Photoimmunol Photomed. 2008;24:222-230.
6. Josefsen LB, Boyle RW. Photodynamic therapy and the development of metal-based photosensitisers. Met-Based Drugs. 2008;2008:276109-276109.
7. Cuomo V, Jori G, Rihter B, Kenney ME, Rodgers MA. Liposome-delivered Si (IV)-naphthalocyanine as a photodynamic sensitiser for experimental tumours: pharmacokinetic and phototherapeutic studies. Br J Cancer. 1990;62: 966-970.
8. Margaron P, Langlois R, van Lier JE, Gaspard S. Photodynamic properties of naphthosulfobenzoporphyrazines, novel asymmetric, amphiphilic phthalocyanine derivatives. J Photochem Photobiol B. 1992;14:187-199.
9. Sessler JL, Magda DJ. Biomedical applications of texaphyrins [abstract]. Free Radic Biol Med. 2006;41(suppl):S8.
10. Wöhrle D, Shopova M, Muller S, Milev AD, Mantareva VN, Krastev KK. Liposome-delivered Zn(II)-2,3-naphthalocyanines as potential sensitizers for PDT: synthesis, photochemical, pharmacokinetic and phototherapeutic studies. J Photochem Photobiol B. 1993;21:155-165.
11. Lv F, He X, Wu L, Liu T. Lactose substituted zinc phthalocyanine: a near infrared fluorescence imaging probe for liver cancer targeting. Bioorg Med Chem Lett. 2013;23:1878-1882.
12. Witjes MJ, Speelman OC, Nikkels PG, et al. In vivo fluorescence kinetics and localisation of aluminum phthalocyanine disulphonate in an autologous tumour model. Br J Cancer. 1996;73:573-580.
13. Ntziachristos V. Going deeper than microscopy: the optical imaging frontier in biology. Nat Methods. 2010;7:603-614.
14. Luke GP, Nam SY, Emelianov SY. Optical wavelength selection for improved spectroscopic photoacoustic imaging. Photoacoustics. 2013;1:36-42.
15. Wheeler BL, Nagasubramanian G, Bard AJ, Schechtman LA, Kenney ME. A silicon phthalocyanine and a silicon naphthalocyanine: synthesis, electrochemistry, and electrogenerated chemiluminescence. J Am Chem Soc. 1984;106:7404-7410.
16. Brasseur N, Nguyen TL, Langlois R, et al. Synthesis and photodynamic activities of silicon 2,3-naphthalocyanine derivatives. J Med Chem. 1994;37:415-420.
17. Brasseur N, Ouellet R, Lewis K, Potter WR, van Lier JE. Photodynamic activities and skin photosensitivity of the bis(dimethylthexylsiloxy)silicon 2,3-naphthalocyanine in mice. Photochem Photobiol. 1995;62:1058-1065.
18. Zhong J, Yang S, Zheng X, Zhou T, Xing D. In vivo photoacoustic therapy with cancer-targeted indocyanine green-containing nanoparticles. Nanomedicine (Lond). 2013;8:903-919.
19. Buehler A, Herzog E, Razansky D, Ntziachristos V. Video rate optoacoustic tomography of mouse kidney perfusion. Opt Lett. 2010;35:2475-2477.
20. Herzog E, Taruttis A, Beziere N, Lutich AA, Razansky D, Ntziachristos V. Optical imaging of cancer heterogeneity with multispectral optoacoustic tomography. Radiology. 2012;263:461-468.
21. Ma R, Taruttis A, Ntziachristos V, Razansky D. Multispectral optoacoustic tomography (MSOT) scanner for whole-body small animal imaging. Opt Express. 2009;17:21414-21426.
22. Buehler A, Rosenthal A, Jetzfellner T, Dima A, Razansky D, Ntziachristos V. Model-based optoacoustic inversions with incomplete projection data. Med Phys. 2011;38:1694-1704.
23. Rosenthal A, Razansky D, Ntziachristos V. Fast semi-analytical model-based acoustic inversion for quantitative optoacoustic tomography. IEEE Trans Med Imaging. 2010;29:1275-1285.
24. Tzoumas S, Deliolanis NC, Morscher S, Ntziachristos V. Unmixing molecular agents from absorbing tissue in multispectral optoacoustic tomography. IEEE Trans Med Imaging. 2014;33:48-60.
25. Ntziachristos V, Razansky D. Molecular imaging by means of multispectral optoacoustic tomography (MSOT). Chem Rev. 2010;110:2783-2794.